Disease Information
General Information of the Disease (ID: DIS00114)
Name |
Multiple sclerosis
|
---|---|
ICD |
ICD-11: 8A40
|
Type(s) of Resistant Mechanism of This Disease
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Teriflunomide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) | [1] | |||
Sensitive Disease | Multiple sclerosis [ICD-11: 8A40.0] | |||
Molecule Alteration | Expression | Down-regulation |
||
Sensitive Drug | Teriflunomide | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | C57BL/6J cells(Mus musculus (Mouse)) | Lymph | Homo sapiens (Human) | CVCL_5U84 |
In Vivo Model | EAE mice model | Mus musculus | ||
Experiment for Drug Resistance |
Annexin V staining assay | |||
Mechanism Description | In vitro, intracellular teri concentration in T cells was 2.5-fold higher in abcg2-kO mice than in wt mice. Teri-induced inhibition of T cell proliferation was two fold increased in abcg2-kO cells compared to wt. | |||
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) | [1] | |||
Sensitive Disease | Multiple sclerosis [ICD-11: 8A40.0] | |||
Molecule Alteration | Expression | Down-regulation |
||
Sensitive Drug | Teriflunomide | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | C57BL/6J cells(Mus musculus (Mouse)) | Lymph | Homo sapiens (Human) | CVCL_5U84 |
In Vivo Model | EAE mice model | Mus musculus | ||
Experiment for Drug Resistance |
Annexin V staining assay | |||
Mechanism Description | Pharmacological abcg2 inhibition in T cells from wt mice led to an increase of teri-induced apoptosis (Ko143 vs. DMSO: 3.1-fold, p < 0.05; FTC vs. DMSO: 2.8-fold, p > 0.05). |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.